Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Axon Axoclamp 900A Microelectrode Amplifier

Product Description
Axon Axoclamp 900A Microelectrode Amplifier
Following the Axoclamp tradition, this amplifier model is a complete microelectrode current clamp and voltage clamp amplifier, useful for a wide range of intracellular microelectrode recording techniques.
The Axoclamp™ 900A Microelectrode Amplifier represents the latest generation of our Axoclamp amplifier family. This model features many enhancements that improve its recording capability, make the amplifier easier to use, and help your experiments last longer.

The Axoclamp 900A Microelectrode Amplifier provides the following modes of operation:

I-Clamp: Current clamp using two independent bridge amplifiers for voltage measurements
DCC: Discontinuous current clamp for accurate voltage measurements, even when the electrode resistance changes
TEVC: High-compliance two-electrode voltage clamp for Xenopus oocytes and mammalian cells
dSEVC: Discontinuous single-electrode voltage clamp for small cells with large currents
HVIC: High-voltage current clamp for extracellular applications such as iontophoresis
Excellent amplifier performance

The ±180 V output compliance used for TEVC and HVIC modes makes it possible to pass larger currents and ensures faster clamp speeds. TEVC and dSEVC modes both have wide AC voltage clamp gain ranges for excellent voltage control. When DC Restore is enabled, the DC voltage clamp gain is greater than 1,000,000, ensuring optimal voltage control for constant-voltage measurements. The new dSEVC design is more stable and twice as fast as before, providing an excellent alternative to standard continuous single-electrode voltage clamping.
Product Axon Axoclamp 900A Microelectrode Amplifier
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos